These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
307 related items for PubMed ID: 24728076
21. Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver. Cui G, Martin RC, Jin H, Liu X, Pandit H, Zhao H, Cai L, Zhang P, Li W, Li Y. J Exp Clin Cancer Res; 2018 Jul 04; 37(1):136. PubMed ID: 29973237 [Abstract] [Full Text] [Related]
23. FGFR redundancy limits the efficacy of FGFR4-selective inhibitors in hepatocellular carcinoma. Tao Z, Cui Y, Xu X, Han T. Proc Natl Acad Sci U S A; 2022 Oct 04; 119(40):e2208844119. PubMed ID: 36179047 [Abstract] [Full Text] [Related]
25. Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development. Uriarte I, Latasa MU, Carotti S, Fernandez-Barrena MG, Garcia-Irigoyen O, Elizalde M, Urtasun R, Vespasiani-Gentilucci U, Morini S, de Mingo A, Mari M, Corrales FJ, Prieto J, Berasain C, Avila MA. Int J Cancer; 2015 May 15; 136(10):2469-75. PubMed ID: 25346390 [Abstract] [Full Text] [Related]
27. Chronic Over-expression of Fibroblast Growth Factor 21 Increases Bile Acid Biosynthesis by Opposing FGF15/19 Action. Zhang J, Gupte J, Gong Y, Weiszmann J, Zhang Y, Lee KJ, Richards WG, Li Y. EBioMedicine; 2017 Feb 15; 15():173-183. PubMed ID: 28041926 [Abstract] [Full Text] [Related]
29. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB. Yang C, Jin C, Li X, Wang F, McKeehan WL, Luo Y. PLoS One; 2012 Feb 15; 7(3):e33870. PubMed ID: 22442730 [Abstract] [Full Text] [Related]
30. FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2. Xie M, Lin Z, Ji X, Luo X, Zhang Z, Sun M, Chen X, Zhang B, Liang H, Liu D, Feng Y, Wang Y, Li Y, Liu B, Huang W, Xia L. J Hepatol; 2023 Jul 15; 79(1):109-125. PubMed ID: 36907560 [Abstract] [Full Text] [Related]
31. Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer. Hu L, Cong L. Oncol Rep; 2015 Nov 15; 34(5):2683-91. PubMed ID: 26323668 [Abstract] [Full Text] [Related]
34. Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis. Gadaleta RM, Scialpi N, Peres C, Cariello M, Ko B, Luo J, Porru E, Roda A, Sabbà C, Moschetta A. Sci Rep; 2018 Nov 21; 8(1):17210. PubMed ID: 30464200 [Abstract] [Full Text] [Related]
39. Hepatocyte FRS2α is essential for the endocrine fibroblast growth factor to limit the amplitude of bile acid production induced by prandial activity. Wang C, Yang C, Chang JY, You P, Li Y, Jin C, Luo Y, Li X, McKeehan WL, Wang F. Curr Mol Med; 2014 Nov 21; 14(6):703-711. PubMed ID: 25056539 [Abstract] [Full Text] [Related]
40. Fibroblast growth factor 19 stimulates water intake. Ursic-Bedoya J, Chavey C, Desandré G, Meunier L, Dupuy AM, Gonzalez-Dopeso Reyes I, Tordjmann T, Assénat E, Hibner U, Gregoire D. Mol Metab; 2022 Jun 21; 60():101483. PubMed ID: 35367668 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]